145 related articles for article (PubMed ID: 15964915)
1. Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets.
Jayachandran M; Sanzo A; Owen WG; Miller VM
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H1908-16. PubMed ID: 15964915
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
Jayachandran M; Mukherjee R; Steinkamp T; LaBreche P; Bracamonte MP; Okano H; Owen WG; Miller VM
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2355-62. PubMed ID: 15653758
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells.
Okano H; Jayachandran M; Yoshikawa A; Miller VM
J Cardiovasc Pharmacol; 2006 Apr; 47(4):621-8. PubMed ID: 16680078
[TBL] [Abstract][Full Text] [Related]
4. Treatment with raloxifene and 17beta-estradiol differentially modulates nitric oxide and prostanoids in venous endothelium and platelets of ovariectomized pigs.
Lewis DA; Avsar M; Labreche P; Bracamonte M; Jayachandran M; Miller VM
J Cardiovasc Pharmacol; 2006 Nov; 48(5):231-8. PubMed ID: 17110805
[TBL] [Abstract][Full Text] [Related]
5. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
[TBL] [Abstract][Full Text] [Related]
6. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression.
Lindmark E; Tenno T; Siegbahn A
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2322-8. PubMed ID: 11031222
[TBL] [Abstract][Full Text] [Related]
7. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.
Zoma WD; Baker RS; Kopernik G; Mershon JL; Clark KE
Am J Obstet Gynecol; 2002 Dec; 187(6):1555-60. PubMed ID: 12501063
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.
Davis AM; Mao J; Naz B; Kohl JA; Rosenfeld CS
J Mol Endocrinol; 2008 Oct; 41(4):205-17. PubMed ID: 18632874
[TBL] [Abstract][Full Text] [Related]
10. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
Shughrue PJ; Lane MV; Merchenthaler I
Endocrinology; 1997 Dec; 138(12):5476-84. PubMed ID: 9389534
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
Reid IR; Eastell R; Fogelman I; Adachi JD; Rosen A; Netelenbos C; Watts NB; Seeman E; Ciaccia AV; Draper MW
Arch Intern Med; 2004 Apr; 164(8):871-9. PubMed ID: 15111373
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of acute and repeated exposure to raloxifene in ovariectomized sheep.
Zoma WD; Baker RS; Mershon JL; Clark KE
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1216-25. PubMed ID: 16517945
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats.
Tsang SY; Yao X; Chan FL; Wong CM; Chen ZY; Laher I; Huang Y
Hypertension; 2004 Jul; 44(1):78-82. PubMed ID: 15159380
[TBL] [Abstract][Full Text] [Related]
14. Conjugated equine estrogens and estradiol benzoate differentially modulate the natriuretic peptide system in spontaneously hypertensive rats.
Firmes LB; Belo NO; Reis AM
Menopause; 2013 May; 20(5):554-60. PubMed ID: 23615647
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
Nguyên P; Broussas M; Cornillet-Lefèbvre P; Potron G
Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
[TBL] [Abstract][Full Text] [Related]
16. Effects of a pure antiestrogen and progesterone on estrogen-mediated alterations of blood flow and progesterone receptor expression in the aorta of ovariectomized rabbits.
Hegele-Hartung C; Fritzemeier KH; Diel P
J Steroid Biochem Mol Biol; 1997; 63(4-6):237-49. PubMed ID: 9459190
[TBL] [Abstract][Full Text] [Related]
17. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Brosnan JF; Sheppard BL; Kelly LA; O'Leary JJ; Norris LA
Thromb Res; 2013 Jan; 131(1):72-7. PubMed ID: 22999413
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
Landry M; Di Paolo T
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.
Somjen D
Crit Rev Eukaryot Gene Expr; 2007; 17(2):115-47. PubMed ID: 17725484
[TBL] [Abstract][Full Text] [Related]
20. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
